Martin Kerzer
Family Medicine · Warwick, RINPI 1962495416
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.2% of the total across 471 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 36 manufacturers, the largest accounting for just 16.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $2,696 and has fallen 99.5% since, to $13 in 2024. Among family medicine clinicians in RI with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 471 payments — averaging $15.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- GSK$1K
- Novo Nordisk$799
- Johnson & Johnson$623
- Pfizer$561
- Boehringer Ingelheim$517
- plus $3K from 30 others
What the payments were for
- Food & beverage$7,29999%
- Education$561%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 77 | $1,206 |
| GSK | 63 | $1,034 |
| Novo Nordisk | 49 | $799 |
| Johnson & Johnson | 38 | $623 |
| Pfizer | 66 | $561 |
| Boehringer Ingelheim | 26 | $517 |
| Sanofi-aventis U.S. LLC | 24 | $494 |
| AbbVie(2 entities) | 29 | $396 |
| Lilly USA, LLC | 17 | $265 |
| E.r. Squibb & Sons, L.L.C. | 6 | $187 |
| Novartis | 10 | $182 |
| Merck | 9 | $130 |
| Amarin Pharma, Inc. | 7 | $125 |
| Grifols USA, LLC | 6 | $100 |
| Regeneron Healthcare Solutions, Inc. | 7 | $95 |
| Biohaven Pharmaceuticals, Inc. | 4 | $91 |
| Astellas Pharma US Inc | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $52 |
| Avanir Pharmaceuticals, Inc. | 3 | $52 |
| Melinta Therapeutics, LLC | 3 | $42 |
| Sunovion Pharmaceuticals Inc. | 4 | $36 |
| Xeris Pharmaceuticals, Inc. | 2 | $33 |
| Mylan Specialty L.p. | 2 | $31 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Abbott | 1 | $21 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $21 |
| Paratek Pharmaceuticals, Inc. | 1 | $20 |
| Kaleo, Inc. | 1 | $18 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Lucid Diagnostics Inc. | 1 | $13 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Amgen | 1 | $13 |
| Biodelivery Sciences International, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ELIQUIS$120
How this compares
$7,354 in reported general payments places this provider in the 90th percentile of 222 family medicine providers in Rhode Island.
Other family medicine in Warwick
- John HoranWarwick$9K
- Michael RekasWarwick$8K
- Gregory SteinmetzWarwick$8K
- Chad LamendolaWarwick$4K
- Keith CallahanWarwick$4K
- Tej BansalWarwick$4K
- Kethelyne BeauvaisWarwick$3K
- Joseph GrandeWarwick$3K
- Pierre CaronWarwick$1K
- Patrick MalloyWarwick$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.